Compare McKesson Corporation (MCK) vs Tencent Music Entertainment Group - ADR (TME) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McKesson Corporation vs Tencent Music Entertainment Group - ADR — how do they compare? McKesson Corporation trades at $823.86 (market cap $97.35B), while Tencent Music Entertainment Group - ADR trades at $8.94 (market cap $15.08B). The key difference: McKesson Corporation is far larger — about 6.5× Tencent Music Entertainment Group - ADR's market cap, and Tencent Music Entertainment Group - ADR pays the higher dividend (2.62%). Which is the better fit depends on your goals.
| MCK | TME | |
|---|---|---|
Market Cap | $97.35B | $15.08B |
Sector | Health | Media |
52-Week High | $995.69 | $26.36 |
52-Week Low | $659.01 | $8.16 |
Enterprise Value | $101.98B | $11.85B |
Dividend Yield | 0.39% | 2.62% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
McKesson Corporation (MCK) trades at $831.60, down 1.16% on the day, with a bullish technical signal and positive earnings momentum after beating estimates for three consecutive quarters. The stock shows strong analyst support with an 80% buy rating and a consensus price target of $932.83, implying potential upside. Revenue growth is robust, reaching $359.05 billion in 2025, though net margins remain thin at 1.18%. Cash flow from operations improved to $6.09 billion in 2025, supporting financial stability.
The outlook for MCK is positive, driven by earnings beats, analyst optimism, and solid cash generation. Key opportunities include growth in specialty pharma and oncology services. Risks involve policy uncertainties, competitive pressures, and execution challenges. The stock's current price near key support at $829 suggests a critical level for near-term direction.
TME trades at $9.19, up 0.77% today, with a bullish technical signal from moving averages. The company reported strong 2025 results with revenue of $32.9B and net income of $11.1B, though recent quarterly earnings have missed expectations. Analyst consensus is mixed with 45.8% buy ratings and a $14 price target, while cash flow trends show significant investment activity.
The outlook remains cautiously optimistic with solid profitability metrics and ecosystem expansion through initiatives like SEND audio technology. Key risks include competitive pressures and execution challenges in premium content delivery. The stock presents value opportunity given reasonable valuation multiples relative to earnings growth potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →About Tencent Music Entertainment Group - ADR
TME is the largest online music service provider in China. It was founded in 2016 with the business combination of QQ Music (founded in 2005), Kuwo Music (founded in 2005) and Kugou Music (founded in 2004) streaming platforms. Tencent is the largest shareholder of TME with over 50% shares and over 90% voting rights held. TME also provides social entertainment services, including music live audio/video broadcasts and online concert services through the three platforms mentioned above, and online karaoke through an independent platform WeSing.
Read more on TME →
